Vaccine Market Analysis, Size, Share & Industry Trends Analysis Report - 2028
The global vaccine market size is expected to reach USD 77.90 Billion at a steady revenue CAGR of 7.1% in 2028, according to latest analysis by Emergen Research. An increase in prevalence of infectious diseases is a key factor driving global vaccine market revenue growth.
Rise
in prevalence of infectious diseases globally increases the healthcare burden
of diseases on countries and affects their socio-economic development.
Emergence of drug-resistant microbial strains that have affected the fight
against infectious diseases such as pneumonia, cholera, malaria, and diarrhea,
among others. Rising demand for new drugs to replace those that have lost
effectiveness and investment in research and development of vaccines is
augmenting growth of the market. Increased funding from public and private
organizations and favorable government regulations has also contributed to
growth of the global vaccine market.
The
report is formulated through extensive primary and secondary research and is
curated with an intent to offer the readers and businesses a competitive edge
over other players in the industry. The report sheds light on the minute
details of the Vaccine industry pertaining to growth factors, opportunities and
lucrative business prospects, regions showing promising growth, and forecast estimation
till 2028.
Get Free Sample PDF @ https://www.emergenresearch.com/request-sample/290
Furthermore,
the report provides a comprehensive analysis of the factors that are likely to
bolster or impede the growth of the market in the coming years. The report
considers the COVID-19 pandemic that is currently unfolding as a key market influencer.
The report provides a thorough estimation of the overall impact of the pandemic
on the Vaccine market and its vital segments. The report also discusses the
impact of the pandemic across different regions of the market. It also offers a
current and future assessment of the impact of the pandemic on the Vaccine market.
Some
Key Highlights from the Report
- In August
2021, Pfizer and BioNTech announced a collaboration with Brazil’s
Eurofarma to manufacture COVID-19 vaccine doses for Latin American
countries. COMIRNATY will be manufactured by Eurofarma with Pfizer’s and
BioNTech’s COVID-19 vaccine manufacturing and supply chain network.
Eurofarma will get raw materials for the drug from the U.S. and
manufacturing will begin in 2022. Vaccine production is expected to exceed
100 million finished doses yearly which will be exclusively distributed
within Latin America.
- Monovalent
vaccine segment revenue is expected to register a significant growth rate
during the forecast period. A monovalent vaccine is designed to immunize
single microorganism and antigen (for example, measles vaccine). This type
of vaccine is preferable for development of a strong immune response.
- Toxoid
vaccines are administered to adults as well as children to protect them
against tetanus and diphtheria. This vaccine is administered to induce an
immune response to protect against disease caused by toxins secreted by
specific bacteria. This vaccine is part of a course of multiple doses and
booster shots are given when travelling to high-risk countries.
- Influenza
segment accounted for a significant revenue in 2020. Influenza vaccines
are seasonal flu shot that protects against the 3–4 types of influenza
viruses such as viral respiratory illness that spreads quite easily. The
flu can lead to serious health complications and even death. CDC
recommends a yearly influenza vaccine for people six months and older.
Pregnant women should also get the vaccine during each pregnancy.
- Vaccine
market in North America accounted for the largest revenue share in 2020
due to the presence of major key players investing in R&D activities,
growing awareness, and subsequent demand for vaccines in the region. High
level of investment in COVID-19 vaccine from the region has contributed to
the growth of the market significantly. Adequate policies for immunization
of various diseases in the region is also driving market growth.
- Some major
players in the market include Pfizer, Inc., CSL Limited, Merck & Co.,
Inc., AstraZeneca, Johnson & Johnson, Serum Institute of India Pvt.,
Ltd., GlaxoSmithKline PLC, Sanofi Pasteur SA, Emergent Biosolutions, Inc.,
and Biological E.
The
report further divides the Vaccine market into key segments such as types,
applications, end-user industries, technologies, and key regions of the market.
The report also sheds light on the segment and region exhibiting promising
growth in the Vaccine market.
Vaccine Market Segmentation
Type
Outlook (Revenue, USD Billion; 2018-2028)
- Monovalent
Vaccines
- Multivalent
Vaccines
Patient
Type Outlook (Revenue, USD Billion; 2018-2028)
- Pediatric
Patients
- Adult
Patients
Application
Technology
Outlook (Revenue, USD Billion; 2018-2028)
- Inactivated
& Subunit Vaccines
- Conjugate
Vaccines
- Recombinant
Vaccines
- Live
Attenuated Vaccines
- Toxoid
Vaccines
Disease
Outlook (Revenue, USD Billion; 2018-2028)
- DTP
- HPV
- Pneumococcal
Disease
- Meningococcal
Disease
- Influenza
- Hepatitis
- Varicella
- MMR
- Polio
- Herpes Zoster
- Rotavirus
- Others
Route
of Administration Outlook (Revenue, USD Billion; 2018-2028)
- Oral
Administration
- Intramuscular
and Subcutaneous Administration
- Others
Regional Segmentation
North America
(U.S., Canada)
Europe (U.K., Italy,
Germany, France, Rest of EU)
Asia Pacific
(India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America
(Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa
(Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a discount on the report @ https://www.emergenresearch.com/request-discount/290
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/vaccine-market
Key Questions Answered by the Report:
Which
region is expected to dominate the market in the coming years?
What
are the recent technological and product advancements occurring in the market?
What
are the key strategies adopted by the prominent players in the Vaccine market?
What
are the key product types and applications of the Vaccine industry?
What
is the outcome of SWOT analysis and Porter’s Five Forces analysis?
How
is the competitive landscape of the Vaccine market?
Who
are the key players in the industry?
What
is the growth rate of the industry over the coming years?
What
will be the valuation of the Vaccine Market by 2028?
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/290
Thank
you for reading the report. The report can be customized as per the requirements
of the clients. For further information or query about customization, please
reach out to us, and we will offer you the report best suited for your needs.
Read Latest Articles of Emergen Research :
https://www.emergenresearch.com/industry-report/plant-based-food-and-beverages-alternatives-market
https://www.emergenresearch.com/industry-report/rapid-liquid-printing-market
https://www.emergenresearch.com/industry-report/smart-product-vending-machines-market
https://www.emergenresearch.com/industry-report/smart-product-vending-machines-market
About Emergen Research
Emergen
Research is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target, and analyze consumer
behavior shifts across demographics, across industries, and help clients make
smarter business decisions. We offer market intelligence studies ensuring
relevant and fact-based research across multiple industries, including
Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update
our research offerings to ensure our clients are aware of the latest trend’s
existent in the market. Emergen Research has a strong base of experienced
analysts from varied areas of expertise. Our industry experience and ability to
develop a concrete solution to any research problems provides our clients with
the ability to secure an edge over their respective competitors.
Press Release Available @ https://www.emergenresearch.com/press-release/global-vaccine-market

Comments
Post a Comment